サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1743035

抗腫瘍漢方注射の世界市場に関する洞察、2031年までの予測

Global Anti-Tumor Chinese Medicine Injection Market Insights, Forecast to 2031

出版日
発行
QYResearch
ページ情報
英文 112 Pages
納期
2～3営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.94円
抗腫瘍漢方注射の世界市場に関する洞察、2031年までの予測
出版日: 2025年06月09日
発行: QYResearch
ページ情報: 英文 112 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、抗腫瘍漢方注射 (Anti-Tumor Chinese Medicine Injection) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査対象

  • 抗腫瘍漢方注射の製品概要
  • 市場：タイプ別
    • 世界の抗腫瘍漢方注射の市場規模成長率：タイプ別, 2020 VS 2024 VS 2031
    • Kanglaite Injection
    • Shenqi Fuzheng Injection
    • Aidi Injection
    • Fufang Kushen Injection
    • Huachan Injection
  • 市場：用途別
    • 世界の抗腫瘍漢方注射の市場規模成長率：用途別, 2020 VS 2024 VS 2031
    • Hospital
    • Clinic
  • 前提条件と制限
  • 調査目的
  • 対象期間

第2章 レポート概要

  • 世界の抗腫瘍漢方注射の収益 推定および予測 2020-2031
  • 世界の収益：地域別
    • 世界の抗腫瘍漢方注射 収益：地域別: 2020 VS 2024 VS 2031
    • 世界の抗腫瘍漢方注射 収益：地域別 (2020-2031)
    • 世界の抗腫瘍漢方注射の収益市場シェア 地域別 (2020-2031)
  • 世界の抗腫瘍漢方注射 売上予測・予想 2020-2031
  • 世界の販売：地域別
    • 世界の抗腫瘍漢方注射 販売：地域別: 2020 VS 2024 VS 2031
    • 世界の抗腫瘍漢方注射 販売：地域別 (2020-2031)
    • 世界の抗腫瘍漢方注射の販売市場シェア 地域別 (2020-2031)
  • 米国・カナダ
  • 欧州
  • 中国
  • アジア（中国を除く）
  • 中東, アフリカ ・ラテンアメリカ

第3章 競合：企業別

  • 世界の販売：企業別
    • 世界の抗腫瘍漢方注射 販売：企業別 (2020-2025)
    • 世界の抗腫瘍漢方注射の販売市場シェア：企業別 (2020-2025)
    • 世界の上位10・上位5企業： 抗腫瘍漢方注射 2024年
  • 世界の収益：企業別
    • 世界の抗腫瘍漢方注射 収益：企業別 (2020-2025)
    • 世界の抗腫瘍漢方注射の収益市場シェア：企業別 (2020-2025)
    • 世界の上位10・上位5企業： 抗腫瘍漢方注射 収益 2024年
  • 世界の主要企業 抗腫瘍漢方注射, 業界ランキング, 2023 VS 2024
  • 世界の抗腫瘍漢方注射の販売価格：企業別 (2020-2025)
  • 競合情勢の分析
    • 企業の市場集中度 (CR5 and HHI)
    • 世界の抗腫瘍漢方注射の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 世界の主要メーカー 抗腫瘍漢方注射, 製造拠点分布と本社
  • 世界の主要メーカー 抗腫瘍漢方注射, 提供製品と用途
  • 世界の主要メーカー 抗腫瘍漢方注射, 業界参入時期
  • M&A, 拡張計画

第4章 市場規模：タイプ別

  • 世界の販売：タイプ別
    • 世界の抗腫瘍漢方注射の販売実績：タイプ別 (2020-2025)
    • 世界の抗腫瘍漢方注射の販売予測：タイプ別 (2026-2031)
    • 世界の抗腫瘍漢方注射の販売市場シェア：タイプ別 (2020-2031)
  • 世界の収益：タイプ別
    • 世界の抗腫瘍漢方注射の収益実績：タイプ別 (2020-2025)
    • 世界の抗腫瘍漢方注射の収益予測：タイプ別 (2026-2031)
    • 世界の抗腫瘍漢方注射の収益市場シェア：タイプ別 (2020-2031)
  • 世界の価格：タイプ別
    • 世界の抗腫瘍漢方注射 価格：タイプ別 (2020-2025)
    • 世界の抗腫瘍漢方注射の価格予測：タイプ別 (2026-2031)

第5章 市場規模：用途別

  • 世界の販売：用途別
    • 世界の抗腫瘍漢方注射の販売実績：用途別 (2020-2025)
    • 世界の抗腫瘍漢方注射の販売予測：用途別 (2026-2031)
    • 世界の抗腫瘍漢方注射の販売市場シェア：用途別 (2020-2031)
  • 世界の収益：用途別
    • 世界の抗腫瘍漢方注射の収益実績：用途別 (2020-2025)
    • 世界の抗腫瘍漢方注射の収益予測：用途別 (2026-2031)
    • 世界の抗腫瘍漢方注射の収益市場シェア：用途別 (2020-2031)
  • 世界の価格：用途別
    • 世界の抗腫瘍漢方注射 価格：用途別 (2020-2025)
    • 世界の抗腫瘍漢方注射の価格予測：用途別 (2026-2031)

第6章 米国・カナダ

  • 米国・カナダ 市場規模：タイプ別
    • 米国・カナダ 抗腫瘍漢方注射 販売：タイプ別 (2020-2031)
    • 米国・カナダ 抗腫瘍漢方注射 収益：タイプ別 (2020-2031)
  • 米国・カナダ 市場規模：用途別
    • 米国・カナダ 抗腫瘍漢方注射 販売：用途別 (2020-2031)
    • 米国・カナダ 抗腫瘍漢方注射 収益：用途別 (2020-2031)
  • 米国・カナダ 市場規模：国別
    • 米国・カナダ 抗腫瘍漢方注射の収益：国別: 2020 VS 2024 VS 2031
    • 米国・カナダ 抗腫瘍漢方注射の収益：国別 (2020-2031)
    • 米国・カナダ 抗腫瘍漢方注射の販売：国別 (2020-2031)
    • US
    • カナダ

第7章 欧州

  • 欧州の市場規模：タイプ別
    • 欧州の抗腫瘍漢方注射 販売：タイプ別 (2020-2031)
    • 欧州の抗腫瘍漢方注射 収益：タイプ別 (2020-2031)
  • 欧州の市場規模：用途別
    • 欧州の抗腫瘍漢方注射 販売：用途別 (2020-2031)
    • 欧州の抗腫瘍漢方注射 収益：用途別 (2020-2031)
  • 欧州の市場規模：国別
    • 欧州の抗腫瘍漢方注射の収益：国別: 2020 VS 2024 VS 2031
    • 欧州の抗腫瘍漢方注射の販売：国別 (2020-2031)
    • 欧州の抗腫瘍漢方注射の収益：国別 (2020-2031)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア

第8章 中国

  • 中国の市場規模：タイプ別
    • 中国の抗腫瘍漢方注射 販売：タイプ別 (2020-2031)
    • 中国の抗腫瘍漢方注射 収益：タイプ別 (2020-2031)
  • 中国の市場規模：用途別
    • 中国の抗腫瘍漢方注射 販売：用途別 (2020-2031)
    • 中国の抗腫瘍漢方注射 収益：用途別 (2020-2031)

第9章 アジア（中国を除く）

  • アジア地域 市場規模：タイプ別
    • アジア地域 抗腫瘍漢方注射 販売：タイプ別 (2020-2031)
    • アジア地域 抗腫瘍漢方注射 収益：タイプ別 (2020-2031)
  • アジア地域 市場規模：用途別
    • アジア地域 抗腫瘍漢方注射 販売：用途別 (2020-2031)
    • アジア地域 抗腫瘍漢方注射 収益：用途別 (2020-2031)
  • アジア地域 市場規模：地域別
    • アジア地域 抗腫瘍漢方注射 収益：地域別: 2020 VS 2024 VS 2031
    • アジア地域 抗腫瘍漢方注射 収益：地域別 (2020-2031)
    • アジア地域 抗腫瘍漢方注射 販売：地域別 (2020-2031)
    • 日本
    • 韓国
    • 台湾
    • 東南アジア
    • インド
    • オーストラリア

第10章 中東, アフリカ ・ラテンアメリカ

  • 中東, アフリカ ・ラテンアメリカの市場規模：タイプ別
    • 中東, アフリカ ・ラテンアメリカの抗腫瘍漢方注射 販売：タイプ別 (2020-2031)
    • 中東, アフリカ ・ラテンアメリカの抗腫瘍漢方注射 収益：タイプ別 (2020-2031)
  • 中東, アフリカ ・ラテンアメリカの市場規模：用途別
    • 中東, アフリカ ・ラテンアメリカの抗腫瘍漢方注射 販売：用途別 (2020-2031)
    • 中東, アフリカ ・ラテンアメリカの抗腫瘍漢方注射 収益：用途別 (2020-2031)
  • 中東, アフリカ ・ラテンアメリカの市場規模：国別
    • 中東, アフリカ ・ラテンアメリカの抗腫瘍漢方注射の収益：国別: 2020 VS 2024 VS 2031
    • 中東, アフリカ ・ラテンアメリカの抗腫瘍漢方注射の収益：国別 (2020-2031)
    • 中東, アフリカ ・ラテンアメリカの抗腫瘍漢方注射の販売：国別 (2020-2031)
    • ブラジル
    • メキシコ
    • トルコ
    • イスラエル
    • 湾岸協力理事会諸国

第11章 企業プロファイル

  • Jemincare
  • Livzon
  • Guizhou Yibai Pharmaceutical
  • Zhendong Health Industry Group
  • CR Sanjiu

第12章 業界チェーンと販売チャネルの分析

  • 抗腫瘍漢方注射 業界チェーン分析
  • 抗腫瘍漢方注射 主要原材料
    • 主要原材料
    • 原材料の主要サプライヤー
  • 抗腫瘍漢方注射 生産形態とプロセス
  • 抗腫瘍漢方注射 販売およびマーケティング
    • 抗腫瘍漢方注射 販売チャネルs
    • 抗腫瘍漢方注射 卸業者
  • 抗腫瘍漢方注射 顧客

第13章 抗腫瘍漢方注射 市場動向

  • 抗腫瘍漢方注射 業界動向
  • 抗腫瘍漢方注射 市場の促進要因
  • 抗腫瘍漢方注射 市場の課題
  • 抗腫瘍漢方注射 市場の抑制要因

第14章 主な調査結果 世界の抗腫瘍漢方注射の主な市場調査結果

第15章 付録

図表

List of Tables

Table 1. Global Anti-Tumor Chinese Medicine Injection Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Major Manufacturers of Kanglaite Injection

Table 3. Major Manufacturers of Shenqi Fuzheng Injection

Table 4. Major Manufacturers of Aidi Injection

Table 5. Major Manufacturers of Fufang Kushen Injection

Table 6. Major Manufacturers of Huachan Injection

Table 7. Global Anti-Tumor Chinese Medicine Injection Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 8. Global Anti-Tumor Chinese Medicine Injection Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 9. Global Revenue by Region (2020-2025) & (US$ Million)

Table 10. Global Revenue Market Share by Region (2020-2031)

Table 11. Global Anti-Tumor Chinese Medicine Injection Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)

Table 12. Global Anti-Tumor Chinese Medicine Injection Sales by Region (2020-2031) & (K Units)

Table 13. Global Sales Market Share by Region (2020-2031)

Table 14. Global Anti-Tumor Chinese Medicine Injection Sales by Manufacturers (2020-2025) & (K Units)

Table 15. Global Anti-Tumor Chinese Medicine Injection Sales Share by Manufacturers (2020-2025)

Table 16. Global Anti-Tumor Chinese Medicine Injection Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 17. Global Anti-Tumor Chinese Medicine Injection Revenue Market Share by Manufacturers (2020-2025)

Table 18. Global Key Players of Anti-Tumor Chinese Medicine Injection, Industry Ranking, 2023 VS 2024 VS 2024

Table 19. Anti-Tumor Chinese Medicine Injection Price by Manufacturers (2020-2025) & (US$/Unit)

Table 20. Global Anti-Tumor Chinese Medicine Injection Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 21. Global Anti-Tumor Chinese Medicine Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Tumor Chinese Medicine Injection as of 2024)

Table 22. Global Key Manufacturers of Anti-Tumor Chinese Medicine Injection, Manufacturing Base Distribution and Headquarters

Table 23. Global Key Manufacturers of Anti-Tumor Chinese Medicine Injection, Product Offered and Application

Table 24. Global Key Manufacturers of Anti-Tumor Chinese Medicine Injection, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Anti-Tumor Chinese Medicine Injection Sales by Type (2020-2025) & (K Units)

Table 27. Global Anti-Tumor Chinese Medicine Injection Sales by Type (2026-2031) & (K Units)

Table 28. Global Sales Share by Type (2020-2031)

Table 29. Global Anti-Tumor Chinese Medicine Injection Revenue by Type (2020-2025) & (US$ Million)

Table 30. Global Anti-Tumor Chinese Medicine Injection Revenue by Type (2026-2031) & (US$ Million)

Table 31. Global Revenue Share by Type (2020-2031)

Table 32. Anti-Tumor Chinese Medicine Injection Price by Type (2020-2025) & (US$/Unit)

Table 33. Global Anti-Tumor Chinese Medicine Injection Price Forecast by Type (2026-2031) & (US$/Unit)

Table 34. Global Anti-Tumor Chinese Medicine Injection Sales by Application (2020-2025) & (K Units)

Table 35. Global Anti-Tumor Chinese Medicine Injection Sales by Application (2026-2031) & (K Units)

Table 36. Global Sales Share by Application (2020-2031)

Table 37. Global Anti-Tumor Chinese Medicine Injection Revenue by Application (2020-2025) & (US$ Million)

Table 38. Global Anti-Tumor Chinese Medicine Injection Revenue by Application (2026-2031) & (US$ Million)

Table 39. Global Revenue Share by Application (2020-2031)

Table 40. Anti-Tumor Chinese Medicine Injection Price by Application (2020-2025) & (US$/Unit)

Table 41. Global Anti-Tumor Chinese Medicine Injection Price Forecast by Application (2026-2031) & (US$/Unit)

Table 42. US & Canada Sales by Type (2020-2031) & (K Units)

Table 43. US & Canada Revenue by Type (2020-2031) & (US$ Million)

Table 44. US & Canada Sales by Application (2020-2031) & (K Units)

Table 45. US & Canada Revenue by Application (2020-2031) & (US$ Million)

Table 46. US & Canada Anti-Tumor Chinese Medicine Injection Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 47. US & Canada Revenue by Country (2020-2031) & (US$ Million)

Table 48. US & Canada Sales by Country (2020-2031) & (K Units)

Table 49. Europe Sales by Type (2020-2031) & (K Units)

Table 50. Europe Revenue by Type (2020-2031) & (US$ Million)

Table 51. Europe Sales by Application (2020-2031) & (K Units)

Table 52. Europe Revenue by Application (2020-2031) & (US$ Million)

Table 53. Europe Anti-Tumor Chinese Medicine Injection Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 54. Europe Sales by Country (2020-2031) & (K Units)

Table 55. Europe Revenue by Country (2020-2031) & (US$ Million)

Table 56. China Sales by Type (2020-2031) & (K Units)

Table 57. China Revenue by Type (2020-2031) & (US$ Million)

Table 58. China Sales by Application (2020-2031) & (K Units)

Table 59. China Revenue by Application (2020-2031) & (US$ Million)

Table 60. Asia Sales by Type (2020-2031) & (K Units)

Table 61. Asia Revenue by Type (2020-2031) & (US$ Million)

Table 62. Asia Sales by Application (2020-2031) & (K Units)

Table 63. Asia Revenue by Application (2020-2031) & (US$ Million)

Table 64. Asia Anti-Tumor Chinese Medicine Injection Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 65. Asia Revenue by Region (2020-2031) & (US$ Million)

Table 66. Asia Sales by Region (2020-2031) & (K Units)

Table 67. Middle East, Africa and Latin America Sales by Type (2020-2031) & (K Units)

Table 68. Middle East, Africa and Latin America Revenue by Type (2020-2031) & (US$ Million)

Table 69. Middle East, Africa and Latin America Sales by Application (2020-2031) & (K Units)

Table 70. Middle East, Africa and Latin America Revenue by Application (2020-2031) & (US$ Million)

Table 71. Middle East, Africa and Latin America Anti-Tumor Chinese Medicine Injection Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 72. Middle East, Africa and Latin America Revenue by Country (2020-2031) & (US$ Million)

Table 73. Middle East, Africa and Latin America Sales by Country (2020-2031) & (K Units)

Table 74. Jemincare Company Information

Table 75. Jemincare Description and Major Businesses

Table 76. Jemincare Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 77. Jemincare Product Model Numbers, Pictures, Descriptions and Specifications

Table 78. Jemincare Recent Developments

Table 79. Livzon Company Information

Table 80. Livzon Description and Major Businesses

Table 81. Livzon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 82. Livzon Product Model Numbers, Pictures, Descriptions and Specifications

Table 83. Livzon Recent Developments

Table 84. Guizhou Yibai Pharmaceutical Company Information

Table 85. Guizhou Yibai Pharmaceutical Description and Major Businesses

Table 86. Guizhou Yibai Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 87. Guizhou Yibai Pharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications

Table 88. Guizhou Yibai Pharmaceutical Recent Developments

Table 89. Zhendong Health Industry Group Company Information

Table 90. Zhendong Health Industry Group Description and Major Businesses

Table 91. Zhendong Health Industry Group Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 92. Zhendong Health Industry Group Product Model Numbers, Pictures, Descriptions and Specifications

Table 93. Zhendong Health Industry Group Recent Developments

Table 94. CR Sanjiu Company Information

Table 95. CR Sanjiu Description and Major Businesses

Table 96. CR Sanjiu Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 97. CR Sanjiu Product Model Numbers, Pictures, Descriptions and Specifications

Table 98. CR Sanjiu Recent Developments

Table 99. Key Raw Materials Lists

Table 100. Raw Materials Key Suppliers Lists

Table 101. Distributors List

Table 102. Customers List

Table 103. Market Trends

Table 104. Market Drivers

Table 105. Market Challenges

Table 106. Market Restraints

Table 107. Research Programs/Design for This Report

Table 108. Key Data Information from Secondary Sources

Table 109. Key Data Information from Primary Sources

List of Figures

Figure 1. Anti-Tumor Chinese Medicine Injection Product Picture

Figure 2. Global Anti-Tumor Chinese Medicine Injection Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Anti-Tumor Chinese Medicine Injection Market Share by Type: 2024 & 2031

Figure 4. Kanglaite Injection Product Picture

Figure 5. Shenqi Fuzheng Injection Product Picture

Figure 6. Aidi Injection Product Picture

Figure 7. Fufang Kushen Injection Product Picture

Figure 8. Huachan Injection Product Picture

Figure 9. Global Anti-Tumor Chinese Medicine Injection Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 10. Global Anti-Tumor Chinese Medicine Injection Market Share by Application: 2024 & 2031

Figure 11. Hospital

Figure 12. Clinic

Figure 13. Anti-Tumor Chinese Medicine Injection Report Years Considered

Figure 14. Global Anti-Tumor Chinese Medicine Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Anti-Tumor Chinese Medicine Injection Revenue (2020-2031) & (US$ Million)

Figure 16. Global Anti-Tumor Chinese Medicine Injection Revenue by Region (2020-2031) (US$ Million)

Figure 17. Global Anti-Tumor Chinese Medicine Injection Revenue Market Share by Region in Percentage: 2024 Versus 2031

Figure 18. Global Anti-Tumor Chinese Medicine Injection Revenue Market Share by Region (2020-2031)

Figure 19. Global Anti-Tumor Chinese Medicine Injection Sales (2020-2031) & (K Units)

Figure 20. Global Anti-Tumor Chinese Medicine Injection Sales (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)

Figure 21. Global Anti-Tumor Chinese Medicine Injection Sales Market Share by Region (2020-2031)

Figure 22. US & Canada Anti-Tumor Chinese Medicine Injection Sales YoY (2020-2031) & (K Units)

Figure 23. US & Canada Anti-Tumor Chinese Medicine Injection Revenue YoY (2020-2031) & (US$ Million)

Figure 24. Europe Anti-Tumor Chinese Medicine Injection Sales YoY (2020-2031) & (K Units)

Figure 25. Europe Anti-Tumor Chinese Medicine Injection Revenue YoY (2020-2031) & (US$ Million)

Figure 26. China Anti-Tumor Chinese Medicine Injection Sales YoY (2020-2031) & (K Units)

Figure 27. China Anti-Tumor Chinese Medicine Injection Revenue YoY (2020-2031) & (US$ Million)

Figure 28. Asia (excluding China) Anti-Tumor Chinese Medicine Injection Sales YoY (2020-2031) & (K Units)

Figure 29. Asia (excluding China) Anti-Tumor Chinese Medicine Injection Revenue YoY (2020-2031) & (US$ Million)

Figure 30. Middle East, Africa and Latin America Anti-Tumor Chinese Medicine Injection Sales YoY (2020-2031) & (K Units)

Figure 31. Middle East, Africa and Latin America Anti-Tumor Chinese Medicine Injection Revenue YoY (2020-2031) & (US$ Million)

Figure 32. Global Anti-Tumor Chinese Medicine Injection Sales Share by Manufacturers (2024)

Figure 33. The Anti-Tumor Chinese Medicine Injection Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2024

Figure 34. Global Anti-Tumor Chinese Medicine Injection Revenue Share by Manufacturers (2024)

Figure 35. The Top 5 and 10 Largest Manufacturers of Anti-Tumor Chinese Medicine Injection in the World: Market Share by Anti-Tumor Chinese Medicine Injection Revenue in 2024

Figure 36. Global Anti-Tumor Chinese Medicine Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 37. Global Anti-Tumor Chinese Medicine Injection Sales Market Share by Type (2020-2031)

Figure 38. Global Anti-Tumor Chinese Medicine Injection Revenue Market Share by Type (2020-2031)

Figure 39. Global Anti-Tumor Chinese Medicine Injection Sales Market Share by Application (2020-2031)

Figure 40. Global Anti-Tumor Chinese Medicine Injection Revenue Market Share by Application (2020-2031)

Figure 41. US & Canada Anti-Tumor Chinese Medicine Injection Sales Market Share by Type (2020-2031)

Figure 42. US & Canada Anti-Tumor Chinese Medicine Injection Revenue Market Share by Type (2020-2031)

Figure 43. US & Canada Anti-Tumor Chinese Medicine Injection Sales Market Share by Application (2020-2031)

Figure 44. US & Canada Anti-Tumor Chinese Medicine Injection Revenue Market Share by Application (2020-2031)

Figure 45. US & Canada Anti-Tumor Chinese Medicine Injection Revenue Share by Country (2020-2031)

Figure 46. US & Canada Anti-Tumor Chinese Medicine Injection Sales Share by Country (2020-2031)

Figure 47. US Anti-Tumor Chinese Medicine Injection Revenue (2020-2031) & (US$ Million)

Figure 48. Canada Anti-Tumor Chinese Medicine Injection Revenue (2020-2031) & (US$ Million)

Figure 49. Europe Anti-Tumor Chinese Medicine Injection Sales Market Share by Type (2020-2031)

Figure 50. Europe Anti-Tumor Chinese Medicine Injection Revenue Market Share by Type (2020-2031)

Figure 51. Europe Anti-Tumor Chinese Medicine Injection Sales Market Share by Application (2020-2031)

Figure 52. Europe Anti-Tumor Chinese Medicine Injection Revenue Market Share by Application (2020-2031)

Figure 53. Europe Anti-Tumor Chinese Medicine Injection Sales Share by Country (2020-2031)

Figure 54. Europe Anti-Tumor Chinese Medicine Injection Revenue Share by Country (2020-2031)

Figure 55. Germany Anti-Tumor Chinese Medicine Injection Revenue (2020-2031) & (US$ Million)

Figure 56. France Anti-Tumor Chinese Medicine Injection Revenue (2020-2031) & (US$ Million)

Figure 57. U.K. Anti-Tumor Chinese Medicine Injection Revenue (2020-2031) & (US$ Million)

Figure 58. Italy Anti-Tumor Chinese Medicine Injection Revenue (2020-2031) & (US$ Million)

Figure 59. Russia Anti-Tumor Chinese Medicine Injection Revenue (2020-2031) & (US$ Million)

Figure 60. China Anti-Tumor Chinese Medicine Injection Sales Market Share by Type (2020-2031)

Figure 61. China Anti-Tumor Chinese Medicine Injection Revenue Market Share by Type (2020-2031)

Figure 62. China Anti-Tumor Chinese Medicine Injection Sales Market Share by Application (2020-2031)

Figure 63. China Anti-Tumor Chinese Medicine Injection Revenue Market Share by Application (2020-2031)

Figure 64. Asia Anti-Tumor Chinese Medicine Injection Sales Market Share by Type (2020-2031)

Figure 65. Asia Anti-Tumor Chinese Medicine Injection Revenue Market Share by Type (2020-2031)

Figure 66. Asia Anti-Tumor Chinese Medicine Injection Sales Market Share by Application (2020-2031)

Figure 67. Asia Anti-Tumor Chinese Medicine Injection Revenue Market Share by Application (2020-2031)

Figure 68. Asia Anti-Tumor Chinese Medicine Injection Revenue Share by Region (2020-2031)

Figure 69. Asia Anti-Tumor Chinese Medicine Injection Sales Share by Region (2020-2031)

Figure 70. Japan Anti-Tumor Chinese Medicine Injection Revenue (2020-2031) & (US$ Million)

Figure 71. South Korea Anti-Tumor Chinese Medicine Injection Revenue (2020-2031) & (US$ Million)

Figure 72. China Taiwan Anti-Tumor Chinese Medicine Injection Revenue (2020-2031) & (US$ Million)

Figure 73. Southeast Asia Anti-Tumor Chinese Medicine Injection Revenue (2020-2031) & (US$ Million)

Figure 74. India Anti-Tumor Chinese Medicine Injection Revenue (2020-2031) & (US$ Million)

Figure 75. Australia Anti-Tumor Chinese Medicine Injection Revenue (2020-2031) & (US$ Million)

Figure 76. Middle East, Africa and Latin America Anti-Tumor Chinese Medicine Injection Sales Market Share by Type (2020-2031)

Figure 77. Middle East, Africa and Latin America Anti-Tumor Chinese Medicine Injection Revenue Market Share by Type (2020-2031)

Figure 78. Middle East, Africa and Latin America Anti-Tumor Chinese Medicine Injection Sales Market Share by Application (2020-2031)

Figure 79. Middle East, Africa and Latin America Anti-Tumor Chinese Medicine Injection Revenue Market Share by Application (2020-2031)

Figure 80. Middle East, Africa and Latin America Anti-Tumor Chinese Medicine Injection Revenue Share by Country (2020-2031)

Figure 81. Middle East, Africa and Latin America Anti-Tumor Chinese Medicine Injection Sales Share by Country (2020-2031)

Figure 82. Brazil Anti-Tumor Chinese Medicine Injection Revenue (2020-2031) & (US$ Million)

Figure 83. Mexico Anti-Tumor Chinese Medicine Injection Revenue (2020-2031) & (US$ Million)

Figure 84. Turkey Anti-Tumor Chinese Medicine Injection Revenue (2020-2031) & (US$ Million)

Figure 85. Israel Anti-Tumor Chinese Medicine Injection Revenue (2020-2031) & (US$ Million)

Figure 86. GCC Countries Anti-Tumor Chinese Medicine Injection Revenue (2020-2031) & (US$ Million)

Figure 87. Value Chain

Figure 88. Anti-Tumor Chinese Medicine Injection Production Process

Figure 89. Channels of Distribution (Direct Vs Distribution)

Figure 90. Bottom-up and Top-down Approaches for This Report

Figure 91. Data Triangulation

Figure 92. Key Executives Interviewed

目次

This research report focuses on the Anti-Tumor Chinese Medicine Injection Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Study Coverage

  • 1.1 Anti-Tumor Chinese Medicine Injection Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Anti-Tumor Chinese Medicine Injection Market Size Growth Rate by Type, 2020 VS 2024 VS 2031
    • 1.2.2 Kanglaite Injection
    • 1.2.3 Shenqi Fuzheng Injection
    • 1.2.4 Aidi Injection
    • 1.2.5 Fufang Kushen Injection
    • 1.2.6 Huachan Injection
  • 1.3 Market by Application
    • 1.3.1 Global Anti-Tumor Chinese Medicine Injection Market Size Growth Rate by Application, 2020 VS 2024 VS 2031
    • 1.3.2 Hospital
    • 1.3.3 Clinic
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Executive Summary

  • 2.1 Global Anti-Tumor Chinese Medicine Injection Revenue Estimates and Forecasts 2020-2031
  • 2.2 Global Revenue by Region
    • 2.2.1 Global Anti-Tumor Chinese Medicine Injection Revenue by Region: 2020 VS 2024 VS 2031
    • 2.2.2 Global Anti-Tumor Chinese Medicine Injection Revenue by Region (2020-2031)
    • 2.2.3 Global Anti-Tumor Chinese Medicine Injection Revenue Market Share by Region (2020-2031)
  • 2.3 Global Anti-Tumor Chinese Medicine Injection Sales Estimates and Forecasts 2020-2031
  • 2.4 Global Sales by Region
    • 2.4.1 Global Anti-Tumor Chinese Medicine Injection Sales by Region: 2020 VS 2024 VS 2031
    • 2.4.2 Global Anti-Tumor Chinese Medicine Injection Sales by Region (2020-2031)
    • 2.4.3 Global Anti-Tumor Chinese Medicine Injection Sales Market Share by Region (2020-2031)
  • 2.5 US & Canada
  • 2.6 Europe
  • 2.7 China
  • 2.8 Asia (excluding China)
  • 2.9 Middle East, Africa and Latin America

3 Competition by Manufacturers

  • 3.1 Global Sales by Manufacturers
    • 3.1.1 Global Anti-Tumor Chinese Medicine Injection Sales by Manufacturers (2020-2025)
    • 3.1.2 Global Anti-Tumor Chinese Medicine Injection Sales Market Share by Manufacturers (2020-2025)
    • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Anti-Tumor Chinese Medicine Injection in 2024
  • 3.2 Global Revenue by Manufacturers
    • 3.2.1 Global Anti-Tumor Chinese Medicine Injection Revenue by Manufacturers (2020-2025)
    • 3.2.2 Global Anti-Tumor Chinese Medicine Injection Revenue Market Share by Manufacturers (2020-2025)
    • 3.2.3 Global Top 10 and Top 5 Companies by Anti-Tumor Chinese Medicine Injection Revenue in 2024
  • 3.3 Global Key Players of Anti-Tumor Chinese Medicine Injection, Industry Ranking, 2023 VS 2024
  • 3.4 Global Anti-Tumor Chinese Medicine Injection Sales Price by Manufacturers (2020-2025)
  • 3.5 Analysis of Competitive Landscape
    • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.5.2 Global Anti-Tumor Chinese Medicine Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.6 Global Key Manufacturers of Anti-Tumor Chinese Medicine Injection, Manufacturing Base Distribution and Headquarters
  • 3.7 Global Key Manufacturers of Anti-Tumor Chinese Medicine Injection, Product Offered and Application
  • 3.8 Global Key Manufacturers of Anti-Tumor Chinese Medicine Injection, Date of Enter into This Industry
  • 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Sales by Type
    • 4.1.1 Global Anti-Tumor Chinese Medicine Injection Historical Sales by Type (2020-2025)
    • 4.1.2 Global Anti-Tumor Chinese Medicine Injection Forecasted Sales by Type (2026-2031)
    • 4.1.3 Global Anti-Tumor Chinese Medicine Injection Sales Market Share by Type (2020-2031)
  • 4.2 Global Revenue by Type
    • 4.2.1 Global Anti-Tumor Chinese Medicine Injection Historical Revenue by Type (2020-2025)
    • 4.2.2 Global Anti-Tumor Chinese Medicine Injection Forecasted Revenue by Type (2026-2031)
    • 4.2.3 Global Anti-Tumor Chinese Medicine Injection Revenue Market Share by Type (2020-2031)
  • 4.3 Global Price by Type
    • 4.3.1 Global Anti-Tumor Chinese Medicine Injection Price by Type (2020-2025)
    • 4.3.2 Global Anti-Tumor Chinese Medicine Injection Price Forecast by Type (2026-2031)

5 Market Size by Application

  • 5.1 Global Sales by Application
    • 5.1.1 Global Anti-Tumor Chinese Medicine Injection Historical Sales by Application (2020-2025)
    • 5.1.2 Global Anti-Tumor Chinese Medicine Injection Forecasted Sales by Application (2026-2031)
    • 5.1.3 Global Anti-Tumor Chinese Medicine Injection Sales Market Share by Application (2020-2031)
  • 5.2 Global Revenue by Application
    • 5.2.1 Global Anti-Tumor Chinese Medicine Injection Historical Revenue by Application (2020-2025)
    • 5.2.2 Global Anti-Tumor Chinese Medicine Injection Forecasted Revenue by Application (2026-2031)
    • 5.2.3 Global Anti-Tumor Chinese Medicine Injection Revenue Market Share by Application (2020-2031)
  • 5.3 Global Price by Application
    • 5.3.1 Global Anti-Tumor Chinese Medicine Injection Price by Application (2020-2025)
    • 5.3.2 Global Anti-Tumor Chinese Medicine Injection Price Forecast by Application (2026-2031)

6 US & Canada

  • 6.1 US & Canada Market Size by Type
    • 6.1.1 US & Canada Anti-Tumor Chinese Medicine Injection Sales by Type (2020-2031)
    • 6.1.2 US & Canada Anti-Tumor Chinese Medicine Injection Revenue by Type (2020-2031)
  • 6.2 US & Canada Market Size by Application
    • 6.2.1 US & Canada Anti-Tumor Chinese Medicine Injection Sales by Application (2020-2031)
    • 6.2.2 US & Canada Anti-Tumor Chinese Medicine Injection Revenue by Application (2020-2031)
  • 6.3 US & Canada Market Size by Country
    • 6.3.1 US & Canada Anti-Tumor Chinese Medicine Injection Revenue by Country: 2020 VS 2024 VS 2031
    • 6.3.2 US & Canada Anti-Tumor Chinese Medicine Injection Revenue by Country (2020-2031)
    • 6.3.3 US & Canada Anti-Tumor Chinese Medicine Injection Sales by Country (2020-2031)
    • 6.3.4 US
    • 6.3.5 Canada

7 Europe

  • 7.1 Europe Market Size by Type
    • 7.1.1 Europe Anti-Tumor Chinese Medicine Injection Sales by Type (2020-2031)
    • 7.1.2 Europe Anti-Tumor Chinese Medicine Injection Revenue by Type (2020-2031)
  • 7.2 Europe Market Size by Application
    • 7.2.1 Europe Anti-Tumor Chinese Medicine Injection Sales by Application (2020-2031)
    • 7.2.2 Europe Anti-Tumor Chinese Medicine Injection Revenue by Application (2020-2031)
  • 7.3 Europe Market Size by Country
    • 7.3.1 Europe Anti-Tumor Chinese Medicine Injection Revenue by Country: 2020 VS 2024 VS 2031
    • 7.3.2 Europe Anti-Tumor Chinese Medicine Injection Sales by Country (2020-2031)
    • 7.3.3 Europe Anti-Tumor Chinese Medicine Injection Revenue by Country (2020-2031)
    • 7.3.4 Germany
    • 7.3.5 France
    • 7.3.6 U.K.
    • 7.3.7 Italy
    • 7.3.8 Russia

8 China

  • 8.1 China Market Size by Type
    • 8.1.1 China Anti-Tumor Chinese Medicine Injection Sales by Type (2020-2031)
    • 8.1.2 China Anti-Tumor Chinese Medicine Injection Revenue by Type (2020-2031)
  • 8.2 China Market Size by Application
    • 8.2.1 China Anti-Tumor Chinese Medicine Injection Sales by Application (2020-2031)
    • 8.2.2 China Anti-Tumor Chinese Medicine Injection Revenue by Application (2020-2031)

9 Asia (excluding China)

  • 9.1 Asia Market Size by Type
    • 9.1.1 Asia Anti-Tumor Chinese Medicine Injection Sales by Type (2020-2031)
    • 9.1.2 Asia Anti-Tumor Chinese Medicine Injection Revenue by Type (2020-2031)
  • 9.2 Asia Market Size by Application
    • 9.2.1 Asia Anti-Tumor Chinese Medicine Injection Sales by Application (2020-2031)
    • 9.2.2 Asia Anti-Tumor Chinese Medicine Injection Revenue by Application (2020-2031)
  • 9.3 Asia Market Size by Region
    • 9.3.1 Asia Anti-Tumor Chinese Medicine Injection Revenue by Region: 2020 VS 2024 VS 2031
    • 9.3.2 Asia Anti-Tumor Chinese Medicine Injection Revenue by Region (2020-2031)
    • 9.3.3 Asia Anti-Tumor Chinese Medicine Injection Sales by Region (2020-2031)
    • 9.3.4 Japan
    • 9.3.5 South Korea
    • 9.3.6 China Taiwan
    • 9.3.7 Southeast Asia
    • 9.3.8 India
    • 9.3.9 Australia

10 Middle East, Africa and Latin America

  • 10.1 Middle East, Africa and Latin America Market Size by Type
    • 10.1.1 Middle East, Africa and Latin America Anti-Tumor Chinese Medicine Injection Sales by Type (2020-2031)
    • 10.1.2 Middle East, Africa and Latin America Anti-Tumor Chinese Medicine Injection Revenue by Type (2020-2031)
  • 10.2 Middle East, Africa and Latin America Market Size by Application
    • 10.2.1 Middle East, Africa and Latin America Anti-Tumor Chinese Medicine Injection Sales by Application (2020-2031)
    • 10.2.2 Middle East, Africa and Latin America Anti-Tumor Chinese Medicine Injection Revenue by Application (2020-2031)
  • 10.3 Middle East, Africa and Latin America Market Size by Country
    • 10.3.1 Middle East, Africa and Latin America Anti-Tumor Chinese Medicine Injection Revenue by Country: 2020 VS 2024 VS 2031
    • 10.3.2 Middle East, Africa and Latin America Anti-Tumor Chinese Medicine Injection Revenue by Country (2020-2031)
    • 10.3.3 Middle East, Africa and Latin America Anti-Tumor Chinese Medicine Injection Sales by Country (2020-2031)
    • 10.3.4 Brazil
    • 10.3.5 Mexico
    • 10.3.6 Turkey
    • 10.3.7 Israel
    • 10.3.8 GCC Countries

11 Corporate Profile

  • 11.1 Jemincare
    • 11.1.1 Jemincare Company Information
    • 11.1.2 Jemincare Overview
    • 11.1.3 Jemincare Anti-Tumor Chinese Medicine Injection Sales, Price, Revenue and Gross Margin (2020-2025)
    • 11.1.4 Jemincare Anti-Tumor Chinese Medicine Injection Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.1.5 Jemincare Recent Developments
  • 11.2 Livzon
    • 11.2.1 Livzon Company Information
    • 11.2.2 Livzon Overview
    • 11.2.3 Livzon Anti-Tumor Chinese Medicine Injection Sales, Price, Revenue and Gross Margin (2020-2025)
    • 11.2.4 Livzon Anti-Tumor Chinese Medicine Injection Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.2.5 Livzon Recent Developments
  • 11.3 Guizhou Yibai Pharmaceutical
    • 11.3.1 Guizhou Yibai Pharmaceutical Company Information
    • 11.3.2 Guizhou Yibai Pharmaceutical Overview
    • 11.3.3 Guizhou Yibai Pharmaceutical Anti-Tumor Chinese Medicine Injection Sales, Price, Revenue and Gross Margin (2020-2025)
    • 11.3.4 Guizhou Yibai Pharmaceutical Anti-Tumor Chinese Medicine Injection Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.3.5 Guizhou Yibai Pharmaceutical Recent Developments
  • 11.4 Zhendong Health Industry Group
    • 11.4.1 Zhendong Health Industry Group Company Information
    • 11.4.2 Zhendong Health Industry Group Overview
    • 11.4.3 Zhendong Health Industry Group Anti-Tumor Chinese Medicine Injection Sales, Price, Revenue and Gross Margin (2020-2025)
    • 11.4.4 Zhendong Health Industry Group Anti-Tumor Chinese Medicine Injection Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.4.5 Zhendong Health Industry Group Recent Developments
  • 11.5 CR Sanjiu
    • 11.5.1 CR Sanjiu Company Information
    • 11.5.2 CR Sanjiu Overview
    • 11.5.3 CR Sanjiu Anti-Tumor Chinese Medicine Injection Sales, Price, Revenue and Gross Margin (2020-2025)
    • 11.5.4 CR Sanjiu Anti-Tumor Chinese Medicine Injection Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.5.5 CR Sanjiu Recent Developments

12 Industry Chain and Sales Channels Analysis

  • 12.1 Anti-Tumor Chinese Medicine Injection Industry Chain Analysis
  • 12.2 Anti-Tumor Chinese Medicine Injection Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Anti-Tumor Chinese Medicine Injection Production Mode & Process
  • 12.4 Anti-Tumor Chinese Medicine Injection Sales and Marketing
    • 12.4.1 Anti-Tumor Chinese Medicine Injection Sales Channels
    • 12.4.2 Anti-Tumor Chinese Medicine Injection Distributors
  • 12.5 Anti-Tumor Chinese Medicine Injection Customers

13 Anti-Tumor Chinese Medicine Injection Market Dynamics

  • 13.1 Anti-Tumor Chinese Medicine Injection Industry Trends
  • 13.2 Anti-Tumor Chinese Medicine Injection Market Drivers
  • 13.3 Anti-Tumor Chinese Medicine Injection Market Challenges
  • 13.4 Anti-Tumor Chinese Medicine Injection Market Restraints

14 Key Findings in the Global Anti-Tumor Chinese Medicine Injection Study

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
      • 15.1.1.1 Research Programs/Design
      • 15.1.1.2 Market Size Estimation
      • 15.1.1.3 Market Breakdown and Data Triangulation
    • 15.1.2 Data Source
      • 15.1.2.1 Secondary Sources
      • 15.1.2.2 Primary Sources
  • 15.2 Author Details
  • 15.3 Disclaimer